Spironolactone trials for Hypertension

All Spironolactone trials · All Hypertension trials

Phase breakdown

Recruiting trials studying Spironolactone for Hypertension

• Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism
  NCT07137364 · Phase: Not specified · Ages: 30 Years to 65 Years · Sex: All (male and female) · 1 location
• Spironolactone for Pulmonary Arterial Hypertension
  NCT01712620 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism
  NCT07328230 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 60 Years · Sex: All (male and female) · 3 locations

Common questions

How many trials study Spironolactone for Hypertension?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.